GLAXF - GlaxoSmithKline's (GSK) CEO Emma Walmsley on Q2 2021 Results - Earnings Call Transcript
GlaxoSmithKline plc (GSK) Q2 2021 Earnings Conference Call July 28, 2021 9:00 AM ET Company Participants Iain Mackay – Chief Financial Officer Emma Walmsley – Chief Executive Officer Luke Miels – President, Global Pharmaceuticals Deborah Waterhouse – Chief Executive Officer, ViiV Healthcare Hal Barron – Chief Scientific Officer, President and R&D Brian McNamara – Chief Executive Officer, Consumer Healthcare Roger Connor – President, GSK Global Vaccines Conference Call Participants Andrew Baum – Citi Laura Sutcliffe – UBS Jo Walton – Credit Suisse James Gordon – JPMorgan Kerry Holford – Berenberg Geoff Porges – SVB Leerink Keyur Parekh – Goldman Sachs Emmanuel Papadakis – Deutsche Bank Graham Parry – BOA Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Analyst Call on the GSK Second Quarter 2021 Results. I will now hand you over to Iain Mackay, CFO, who will introduce today’s session. Iain Mackay Good morning, and good
For further details see:
GlaxoSmithKline's (GSK) CEO Emma Walmsley on Q2 2021 Results - Earnings Call Transcript